Latisse®
New Prescription Product Increases Length, Thickness And Darkness Of Eyelashes
LATISSE® solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. increases the growth of eyelashes, making them longer, thicker and darker
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE® is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
Available only through a doctor, LATISSE® is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE® users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE® is required. If use of LATISSE® is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).
Bimatoprost
is the active pharmaceutical ingredient in the formulation of LATISSE®
and is a
structural prostaglandin analog, a lipid compound derived from fatty acids
designed to bind to prostaglandin (PG) receptors. PG receptors are present in
hair, particularly in the dermal papilla and outer root sheath. Although the
precise mechanism of action is unknown, PG receptors are thought to be involved
in the development and regrowth of the hair follicle, by increasing the percent
of hairs in, and the duration of, the anagen or growth phase.
Latisse® information from Allergan, Inc.
Latisse® Eyelash Extension